Suppr超能文献

通痹散对高脂肪饮食诱导肥胖小鼠模型的抗肥胖作用。

The anti-obesity effects of Tongbi-san in a high-fat diet-induced obese mouse model.

机构信息

Department of Pharmacology, College of Korean Medicine, Sangji University, 83, Sangjidae-gil, Wonju-si, Gangwon-do, 26339, Republic of Korea.

Fubonic Cor. 200 Gieopdosi-ro, Jijeong-myeon, Wonju, Gangwon-do, Republic of Korea.

出版信息

BMC Complement Altern Med. 2019 Jan 3;19(1):1. doi: 10.1186/s12906-018-2420-5.

Abstract

BACKGROUND

Recently, it has been noted that natural herbal medications may be effective in treating obesity. Tongbi-san (TBS) is a traditional medicine usually used for dysuria (i.e., painful urination), containing three herbs, Cyperus rotundus L., Citrus unshiu Markovich, and Poria cocos. In this study, we aimed to examine whether TBS can inhibit high-fat diet (HFD)-induced adipogenesis in the liver and epididymal adipose tissue of obese mice.

METHODS

Male C57BL/6 N mice were fed a normal diet, an HFD, an HFD plus orlistat 10 or 20 mg/kg, or an HFD plus TBS 50 or 100 mg/kg for 11 weeks. Body weight was checked weekly and histological tissue examinations were investigated. An expression of genes involved in adipogenesis was also assessed.

RESULTS

Oral administration of TBS significantly reduced body weight and decreased epididymal and visceral white adipose tissue (WAT) weight. In addition, we found that TBS enhanced the expression of the adenosine monophosphate-activated protein kinase (AMPK) and inhibited the expression of transcription factors, such as CCAAT/enhancer-binding proteins (C/EBPs), sterol regulatory element-binding protein 1 (SREBP1), and peroxisome proliferator-activated receptor γ (PPARγ) in the liver and epididymal WAT as measured by quantitative reverse transcription polymerase chain reaction (qRT-PCR).

CONCLUSION

These findings demonstrate that the anti-obesity effects of TBS may be linked to the activation of AMPK.

摘要

背景

最近,人们注意到天然草药可能对治疗肥胖有效。通痹散(TBS)是一种传统药物,通常用于治疗尿痛(即尿痛),含有三种草药:香附、橘子和茯苓。在这项研究中,我们旨在研究 TBS 是否能抑制高脂肪饮食(HFD)诱导的肥胖小鼠肝脏和附睾脂肪组织中的脂肪生成。

方法

雄性 C57BL/6N 小鼠分别喂食正常饮食、HFD、HFD 加奥利司他 10 或 20mg/kg、或 HFD 加 TBS 50 或 100mg/kg,共 11 周。每周检查体重,并进行组织学检查。还评估了参与脂肪生成的基因的表达。

结果

TBS 口服给药可显著降低体重,并减少附睾和内脏白色脂肪组织(WAT)的重量。此外,我们发现 TBS 增强了腺苷一磷酸激活蛋白激酶(AMPK)的表达,并通过定量逆转录聚合酶链反应(qRT-PCR)抑制了肝脏和附睾 WAT 中转录因子如 CCAAT/增强子结合蛋白(C/EBPs)、固醇调节元件结合蛋白 1(SREBP1)和过氧化物酶体增殖物激活受体 γ(PPARγ)的表达。

结论

这些发现表明 TBS 的抗肥胖作用可能与 AMPK 的激活有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2406/6319014/ccc583589bd0/12906_2018_2420_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验